Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
C 173.62 -3.51% -6.32
KRYS closed down 3.51 percent on Friday, April 12, 2024, on 63 percent of normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Multiple of Ten Bearish Other -3.51%
Overbought Stochastic Strength -3.51%
20 DMA Support Bullish -1.18%
Doji - Bullish? Reversal -1.18%
Overbought Stochastic Strength -1.18%
Gapped Down Weakness -1.18%
Boomer Buy Setup Bullish Swing Setup -3.42%
NR7 Range Contraction -3.42%
Multiple of Ten Bearish Other -3.42%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Krystal Biotech, Inc. Description

Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Clinical Development Rare Diseases Inflammation Gene Therapy Genetic Diseases Genodermatoses Herpes Epidermolysis Bullosa Dehydration Herpes Simplex Netherton Syndrome Herpes Simplex Virus Skin Inflammation Dermatological Diseases Ichthyosis Itchiness

Is KRYS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 189.97
52 Week Low 82.09
Average Volume 420,816
200-Day Moving Average 126.37
50-Day Moving Average 152.94
20-Day Moving Average 174.72
10-Day Moving Average 177.88
Average True Range 7.10
RSI (14) 54.13
ADX 33.19
+DI 21.78
-DI 16.54
Chandelier Exit (Long, 3 ATRs) 161.21
Chandelier Exit (Short, 3 ATRs) 185.05
Upper Bollinger Bands 183.47
Lower Bollinger Band 165.98
Percent B (%b) 0.44
BandWidth 10.01
MACD Line 5.80
MACD Signal Line 7.38
MACD Histogram -1.5842
Fundamentals Value
Market Cap 4.9 Billion
Num Shares 28.2 Million
EPS -1.17
Price-to-Earnings (P/E) Ratio -148.39
Price-to-Sales 367.12
Price-to-Book 4.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 184.90
Resistance 3 (R3) 185.47 182.28 183.02
Resistance 2 (R2) 182.28 179.41 182.00 182.39
Resistance 1 (R1) 177.95 177.64 176.36 177.38 181.77
Pivot Point 174.76 174.76 173.97 174.48 174.76
Support 1 (S1) 170.43 171.89 168.84 169.86 165.47
Support 2 (S2) 167.24 170.12 166.96 164.85
Support 3 (S3) 162.91 167.24 164.22
Support 4 (S4) 162.34